What's New
Last Posted: Apr 12, 2020
- Lipoprotein(a) and COVID-19
S Seim, Th FH FOundtaion, April 8, 2020 - Artificial intelligence for the diagnosis of heart failure
DJ Choi et al, NPJ Digital Medicine, April 8, 2020 - Familial hypercholesterolemia and COVID-19: triggering of increased sustained cardiovascular risk.
Vuorio Alpo et al. Journal of internal medicine 2020 Apr - Antisense oligonucleotides for atherosclerotic disease
A Bajaj et al Nature Medicine, April 6, 2020 - Accuracy of Smartphone Camera Applications for Detecting Atrial Fibrillation- A Systematic Review and Meta-analysis
JW O'SUllivan et al, JAMA Network Open, April 3, 2020 - Primordial Cardiovascular Prevention Draws Closer
B Jancin, Medscape, March 30, 2020 - Epigenetic Therapeutics for Cardiovascular Disease- Writing, Erasing, Reading, and Maybe Forgetting
J Plutzky, JAMA, March 27, 2020 - Heart Disease Family Health History, and Familial Hypercholesterolemia
CDC, March 2020 - Effect of Home Blood Pressure Monitoring via a Smartphone Hypertension Coaching Application or Tracking Application on Adults With Uncontrolled Hypertension- A Randomized Clinical Trial
SD Persell et al, JAMA Network Open, March 2, 2020 - Association of Long-term Exposure to Elevated Lipoprotein(a) Levels With Parental Life Span, Chronic Disease–Free Survival, and Mortality Risk- A Mendelian Randomization Analysis
B Arsenault et al, JAMA Network Open, February 27, 2020 - FDA approves bempedoic acid/ezetimibe for LDL lowering in ASCVD, HeFH
CM Ballantyne, Healio News, February 27, 2020 - Making Informed CHOICES: The Launch of a "Big Data" Pragmatic Trial to Improve Cholesterol Management and Prevent Heart Disease in Ontario.
Ferreira-Legere Laura E et al. Healthcare quarterly (Toronto, Ont.) 2020 Jan 22(4) 6-9 - Machine Learning and Deep Neural Networks Applications in Coronary Flow Assessment: The Case of Computed Tomography Fractional Flow Reserve.
Tesche Christian et al. Journal of thoracic imaging 2020 Feb - Screening for chronic conditions with reproductive factors using a machine learning based approach.
Tian Siyu et al. Scientific reports 2020 Feb 10(1) 2848 - The Potential Benefits of Deferred Payment for a Hypothetical Gene Therapy for Congestive Heart Failure: A Cost-Consequence Analysis.
Hlávka Jakub P et al. Applied health economics and health policy 2020 Feb - Translational Genomics in Neurocritical Care: a Review.
Myserlis Pavlos et al. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2020 Feb - Biological Versus Chronological Aging- JACC Focus Seminar
JACC Focus Seminar, February 2020 - Aspirin for Prevention of Cardiovascular Disease
AT Peters et al, JAMA Patient Page, February 18, 2020 - Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.
Limdi Nita A et al. The pharmacogenomics journal 2020 Feb - Do Polygenic Risk Scores Improve Patient Selection for Prevention of Coronary Artery Disease?
SS Khan et al, JAMA Editorial, February 18, 2020
No hay comentarios:
Publicar un comentario